Aesculap Revenue and Competitors
Estimated Revenue & Valuation
- Aesculap's estimated annual revenue is currently $428.5M per year.
- Aesculap's estimated revenue per employee is $251,000
Employee Data
- Aesculap has 1707 Employees.
Aesculap's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Lab Manager-Biology, Chemistry and Forensics | Reveal Email/Phone |
Aesculap Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $73.5M | 302 | 26% | N/A | N/A |
#2 | $7M | 23 | 0% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 35 | 17% | N/A | N/A |
#6 | $56.2M | 121 | -18% | N/A | N/A |
#7 | $38.9M | 137 | 10% | N/A | N/A |
#8 | $22.1M | 85 | 18% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is Aesculap?
Advances in healthcare are made from a willingness to face change with innovative solutions which shape the future of medicine. This means taking responsibility for recognizing opportunities in the marketplace and identifying the customer’s needs. As a leading healthcare company, Aesculap is fully aware of this responsibility. The brand promise, “Sharing Expertise,” stands for the continual exchange of knowledge and experience in medicine
keywords:N/A
N/A
Total Funding
1707
Number of Employees
$428.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aesculap News
... Development Forecast 2022-2030| Aesculap, Arthrex, Arthro Surface ... in the global Unicompartmental Knee Prostheses market are Aesculap
Dermatome Device Market 2022-2029 Know About Growth Rate, Trends, Segmentation and Key Players Nouvag, Aesculap, B Braun. By. CDN Newswire.
Joint Reconstruction Market Emerging Players May Yields New Opportunities: Aesculap Implants System, Abs Corporation · Joint Reconstruction...
Other Companies in Center Valley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1457.3M | 5006 | 5% | N/A |